(1)
ABOUHUSSEIN, D.; TEAIMA, M. H.; AL-NUSEIRAT, A.; BADARY, O.; EL-NABARAWI, M. A.; EL-MONEM, R. A. FORMULATION AND CHARACTERIZATION OF ODT USING DIFFERENT CO-PROCESS CONTAINING DACLATSVIR: IN VITRO AND IN VIVO PHARMACOKINETICS STUDY ON HEALTHY VOLUNTEERS FOR HEPATITIS C TREATMENT. Int J App Pharm 2022, 14, 105-112.